AMP German Cannabis Group Announces Non-Brokered Placement Private Placement to Fund German Medical Cannabis Import Business
(firmenpresse) - THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES
BERLIN, Germany, January 8, 2020 - AMP German Cannabis Group Inc. (AMP or the Company) (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces a non-brokered placement of up to 8,000,000 common shares of the Company at a price of $0.25 per share for gross proceeds of up to $2,000,000.
The Company intends to use the net proceeds from the offering to fund its import business, general corporate purposes and working capital. All securities issued pursuant to the offering will be subject to a statutory hold period of four months plus a day from issuance in accordance with applicable securities laws.
In connection with the offering, the Company may pay a finder''s fee and warrants to one or more arm''s length parties.
About AMP German Cannabis Group Inc.
AMP German Cannabis Group is a specialized importer of EU-GMP medical cannabis from European and non-European countries into Germany. For more information, please visit: www.amp-eu.com.
Contact:
Mr. Alex Blodgett, CEO and Director
Telephone: +236-833-1602
Canada: investor(at)amp-eu.com
Germany: investor(at)amp-eu.de
Social media links: Twitter, Reddit, LinkedIn, and Facebook. Media Kit: www.amp-eu.com/media-kit
Cautionary Statements
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the shares in the United States. The shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
This news release contains forward-looking statements that are based on the Company''s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the completion of the offering, the timing thereof and the expected use of proceeds from the offering. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
SOURCE AMP German Cannabis Group Inc.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Osisko Highlights Achievements from 2019Datum: 09.01.2020 - 01:30 Uhr
Sprache: Deutsch
News-ID 1555113
Anzahl Zeichen: 2230
contact information:
Contact person:
Town:
Wien
Phone:
Kategorie:
Business News
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 638 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"AMP German Cannabis Group Announces Non-Brokered Placement Private Placement to Fund German Medical Cannabis Import Business
"
steht unter der journalistisch-redaktionellen Verantwortung von
AMP German Cannabis Group Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
